543 related articles for article (PubMed ID: 35750927)
1. Signalling mechanisms and cellular functions of SUMO.
Vertegaal ACO
Nat Rev Mol Cell Biol; 2022 Nov; 23(11):715-731. PubMed ID: 35750927
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress.
Baczyk D; Audette MC; Coyaud E; Raught B; Kingdom JC
J Physiol; 2018 May; 596(9):1587-1600. PubMed ID: 29468681
[TBL] [Abstract][Full Text] [Related]
3. Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?
Cheng X; Yang W; Lin W; Mei F
Pharmacol Rev; 2023 Sep; 75(5):979-1006. PubMed ID: 37137717
[TBL] [Abstract][Full Text] [Related]
4. System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.
Xiao Z; Chang JG; Hendriks IA; Sigurðsson JO; Olsen JV; Vertegaal AC
Mol Cell Proteomics; 2015 May; 14(5):1419-34. PubMed ID: 25755297
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive compilation of SUMO proteomics.
Hendriks IA; Vertegaal AC
Nat Rev Mol Cell Biol; 2016 Sep; 17(9):581-95. PubMed ID: 27435506
[TBL] [Abstract][Full Text] [Related]
6. Mapping the SUMOylated landscape.
Eifler K; Vertegaal AC
FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
[TBL] [Abstract][Full Text] [Related]
7. SUMO: From Bench to Bedside.
Chang HM; Yeh ETH
Physiol Rev; 2020 Oct; 100(4):1599-1619. PubMed ID: 32666886
[TBL] [Abstract][Full Text] [Related]
8. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation and cell signalling.
Andreou AM; Tavernarakis N
Biotechnol J; 2009 Dec; 4(12):1740-52. PubMed ID: 19946876
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin and SUMO Modifications in
Drabikowski K
Curr Issues Mol Biol; 2020; 35():145-158. PubMed ID: 31422938
[TBL] [Abstract][Full Text] [Related]
11. Small ubiquitin-related modifiers in chains.
Vertegaal AC
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1422-3. PubMed ID: 18031236
[TBL] [Abstract][Full Text] [Related]
12. Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum.
Reiter K; Mukhopadhyay D; Zhang H; Boucher LE; Kumar N; Bosch J; Matunis MJ
J Biol Chem; 2013 Sep; 288(39):27724-36. PubMed ID: 23943616
[TBL] [Abstract][Full Text] [Related]
13. The post-translational modification, SUMOylation, and cancer (Review).
Han ZJ; Feng YH; Gu BH; Li YM; Chen H
Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications.
Sohn SY; Hearing P
mBio; 2019 Feb; 10(1):. PubMed ID: 30808699
[TBL] [Abstract][Full Text] [Related]
15. The strategies for identification and quantification of SUMOylation.
Zhang Y; Li Y; Tang B; Zhang CY
Chem Commun (Camb); 2017 Jun; 53(52):6989-6998. PubMed ID: 28589199
[TBL] [Abstract][Full Text] [Related]
16. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
17. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs.
Zhao Q; Xie Y; Zheng Y; Jiang S; Liu W; Mu W; Liu Z; Zhao Y; Xue Y; Ren J
Nucleic Acids Res; 2014 Jul; 42(Web Server issue):W325-30. PubMed ID: 24880689
[TBL] [Abstract][Full Text] [Related]
18. SUMO and the DNA damage response.
Bhachoo JS; Garvin AJ
Biochem Soc Trans; 2024 Apr; 52(2):773-792. PubMed ID: 38629643
[TBL] [Abstract][Full Text] [Related]
19. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
20. Insights in Post-Translational Modifications: Ubiquitin and SUMO.
Salas-Lloret D; González-Prieto R
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
